Dr. George Poste, cbe
Dr Poste is Chief Executive Officer of Health Technology
Networks, a healthcare consulting group based in Scottsdale, Arizona and suburban
Philadelphia. He is Chairman of the Department of Defense Task Force on the
Protection of the United States Against Bioterrorism. He is considered one of the leading
Epidemiologists in the country, and sought regularly by federal agencies for his knowledge
and research on C&B (chemical warfare and bio-terrorism).
From 1992 to 1999 he was President, R&D and Chief Science and Technology Officer at SmithKline Beecham (SB) and a member of the Board of Directors. During his tenure in the pharmaceutical industry he was associated with 29 successful drug and vaccine registrations in the USA and internationally.
He is non-executive Chairman of diaDexus, the joint venture in molecular diagnostics between SmithKline Beecham and Incyte Pharmaceuticals located in Santa Clara and non-Executive Chairman of Structural GenomiX in San Diego. He serves on the Board of Directors of Maxygen in Palo Alto, Orchid BioSciences in Princeton and Illumina in San Diego. He also advises several capital funds and investment banks.
He was educated in England and received a Doctorate in
Veterinary Medicine in 1966 and a Ph.D. in Virology in 1969 from the University of
Bristol. He is a Board-certified Pathologist
and was awarded a D.Sc. for meritorious research contributions by his alma mater in 1987. He was elected Fellow, Royal College of Veterinary
Surgeons, London in 1987, Fellow of the Royal College of Pathologists London in 1989,
Fellow of the Royal College of Physicians, London in 1993, a Fellow of The Royal Society
in 1997 and a Founder Fellow of the Academy of Medical Sciences in the UK in 1998. He was awarded an honorary Doctor of Laws (LL.D.)
by the University of Bristol in 1995 and by the University of Dundee in 1998 for his
contributions to international health policy. Dr.
Poste was awarded the honor of Knight Commander of the Order of the British Empire (CBE)
by Queen Elizabeth in 1999 for services to the development of biosciences.
He holds the William Pitt Fellow at Pembroke
College, Cambridge University, is a Fellow of University College, London and Distinguished
Visiting Fellow at the Hoover Institution at Stanford University.
He has published over 300 scientific papers
and co-edited 15 books, primarily in the fields of cancer research and drug delivery. He is co-founder of Cancer and Metastasis
Reviews and Advanced Drug Delivery Reviews, a past Chairman of the Editorial
Board of the journal, Nature Bio/Technology, serves on the Editorial Boards of
several journals and also writes a regular column for the Financial Times.
He has served on numerous committees for the UK and US governments including the Human Genetics Advisory Commission in the UK and the Department of Defense Science Board in the USA. He is currently the Chair of the Department of Defense Task Force on the Protection of the United States Against Bioterrorism.
Dr. Poste is a naturalized US Citizen and is
married with three children. His personal
interests are in automobile racing, military history, photography and exploring the
deserts of the American Southwest.
